Related references
Note: Only part of the references are listed.Application of Cell-Free DNA Analysis to Cancer Treatment EDITORIAL COMMENT
Mary E. Norton
OBSTETRICAL & GYNECOLOGICAL SURVEY (2019)
Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)
Shilpa Thakur et al.
FRONTIERS IN ONCOLOGY (2019)
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology
Thayse Lozovoy Madsen Barbosa et al.
BMC ENDOCRINE DISORDERS (2019)
Analytical Performance of the ThyroSeq v3 Genomic Classifier for Cancer Diagnosis in Thyroid Nodules
Marina N. Nikiforova et al.
CANCER (2018)
Current methodologies for molecular screening of thyroid nodules
Elisabetta Macerola et al.
GLAND SURGERY (2018)
Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer
J. V. Schou et al.
ANNALS OF ONCOLOGY (2018)
Integrity and Quantity of Total Cell-Free DNA in the Diagnosis of Thyroid Cancer: Correlation with Cytological Classification
Francesca Salvianti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES
Chetan Bettegowda et al.
NEURO-ONCOLOGY (2014)
Circulating BRAFV600E in the Diagnosis and Follow-Up of Differentiated Papillary Thyroid Carcinoma
C. Pupilli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples
Yuri E. Nikiforov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Is the role of circulating DNA as a biomarker of cancer being prematurely overrated?
Maniesh van der Vaart et al.
CLINICAL BIOCHEMISTRY (2010)
Molecular Classification of Thyroid Nodules Using High-Dimensionality Genomic Data
Darya Chudova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer
Heidi Schwarzenbach et al.
CIRCULATING NUCLEIC ACIDS IN PLASMA AND SERUM V (2008)
Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer
Raquel Catarino et al.
DNA AND CELL BIOLOGY (2008)
Circulating (cell-free) nucleic acids - A promising, non-invasive tool for early detection of several human diseases
Vishnu Swarup et al.
FEBS LETTERS (2007)
Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography
Mary C. Frates et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer
BR Smith et al.
THYROID (2006)
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer
Felix K. -H. Chun et al.
BJU INTERNATIONAL (2006)
Share Paper
